WASATCH ADVISORS LP - 30 Apr 2025 SCHEDULE 13G/A Report for C4 Therapeutics, Inc. Common Stock (CCCC)

Filing Manager
WASATCH ADVISORS LP
Reporting Manager
WASATCH ADVISORS LP
Symbol
CCCC
Shares outstanding
71.2M shares
Disclosed Ownership
7.47M shares
Ownership
10.5%
Form type
SCHEDULE 13G/A
Filing time
07 May 2025, 13:39:49 UTC
Date of event
30 Apr 2025
Next filing
13 Nov 2025

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
WASATCH ADVISORS LP 10.5% 7.47M 6.75M 0 Mike Yeates CEO